论文部分内容阅读
目的探讨烟酸占替诺治疗脑梗塞的临床疗效。方法将2007年~2013年收治的75例脑梗塞患者，随机分为治疗组(38例)和对照组(37例)。治疗组采用烟酸占替诺注进行治疗，对照组采用川芎嗪进行治疗，观察两组的临床疗效。结果烟酸占替诺组38例，其中治愈18例，显效10例，有效7例，有效率92.11豫；川芎嗪组37例，其中治愈10例，显效8例，有效8例，无效11例，有效率70.27豫；烟酸占替诺组的疗效明显优于川芎嗪组，差异有统计学意义(<0.01)。结论应用烟酸占替诺治疗脑梗塞患者，疗效确切，安全经济，值得临床推广应用。“,”Objective To explore the diagnosis and treatment of niacin tenofovir cerebral infarction clinical curative ef ect.Methods From 2007 to 2013 were treated 75 cases of cerebral infarction patients, randomly divided into treatment group (38 cases) and control group (37 cases). Treatment group were treated with Xantinol nicotinate injection treatment, control group with Ligustrazine treatment, observes two groups of clinical curative ef ects.Results Xanthinol nicotinate group 38 cases, 18 cases were cured, 10 cases markedly ef ective, ef ective 7 cases, ef ective 92.11%;Ligustrazine group 37 cases, 10 cases were cured, 8 cases markedly ef ective, ef ective 8 cases, invalid 11 cases, ef iciency 70.27%; nicotinic acid accounted for ef ect of Connaught Group was significantly bet er than the Ligustrazine group, have statistical y significant dif erences ( <0.01).Conclusion Application of nicotinic acid of tenofovir therapy in patients with cerebral infarction, curative ef ect, safe and economic, worthy of clinical popularization and application.